Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0005
+0.0001 (25.00%)
Nov 4, 2025, 10:34 AM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Gene Control Medicines
9.94M
Log In
Log In
Log In
Log In
Upgrade
Gene Control Medicines Growth
-33.23%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192014 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
United States
9.94M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-33.23%
Log In
Log In
Log In
Log In
Upgrade